CS
Chris Schott JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
10%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85.7%
Neutral
10.7%
Negative
3.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $35 |
8%
upside
| 4 | +18% |
0
%
| 16 Dec ‘25 22 days ago |
|
|
|
Neutral
Maintained
| $18 |
23%
upside
| 3 | -36% |
0
%
| 15 Dec ‘25 23 days ago |
|
|
|
Overweight
Maintained
| $1,150 |
4%
upside
| 3 | +19% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Underweight
Maintained
| $12 |
51%
upside
| 1 | -4.7% |
0
%
| 11 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $200 |
56%
upside
| 1 | +3.9% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $775 |
10%
upside
| 2 | +16% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $260 |
15%
upside
| 2 | +1.4% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $150 |
22%
upside
| 5 | +5.4% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Upgraded
| $24 |
1%
upside
| 1 | +15% |
0
%
| 7 Oct ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $14 |
5%
upside
| 2 | +29% |
0
%
| 16 Sep ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $800 |
1%
upside
| 3 | +11% |
0
%
| 9 Jun ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $175 |
5%
downside
| 1 | – |
–
| 5 May ‘25 8 months ago |
|